Icon's $12B buy of PRA Health leads busy German advisory slate
What's the deal? A cluster of new legal mandates has emerged across German and European dealmaking, led by clinical research firm Icon's $12 billion acquisition of PRA Health SciencesDealroom has a profile for this one. Try Dealroom →. Noerr is advising Icon on the transaction with Fabian Badtke and Jens Peter Schmidt.
What else is moving? Siemens is buying chip verification firm OneSpin Solutions, with DLA Piper advising the buyer via Gerald Schumann. Elsewhere, KKR is selling a 25.1% stake in defence electronics group Hensoldt to Leonardo; Hengeler Mueller advises KKR, while Clifford Chance acts for Leonardo.
Who's raising capital? Peptide maker PolypeptideDealroom has a profile for this one. Try Dealroom → is going public, with Clifford Chance advising the company and Linklaters guiding the bank syndicate. Hogan Lovells is supporting coordinators JefferiesDealroom has a profile for this one. Try Dealroom → and Unicredit on a capital increase at Deutsche Beteiligungs AGDealroom has a profile for this one. Try Dealroom →.
What's on the M&A ledger? ArmiraDealroom has a profile for this one. Try Dealroom → has mandated Norton Rose Fulbright for its purchase of SalesfiveDealroom has a profile for this one. Try Dealroom →, and White & Case is advising Lime TechnologiesDealroom has a profile for this one. Try Dealroom → on its acquisition of UserlikeDealroom has a profile for this one. Try Dealroom →. Simmons & Simmons is standing beside GimvDealroom has a profile for this one. Try Dealroom → on its investment in the Apraxon group.
Deutsche BörseDealroom has a profile for this one. Try Dealroom → is drawing on Noerr's Holger H. Ebersberger for its investment in new digital marketplaces. On the lending side, Görg is advising Sparkasse KölnBonnDealroom has a profile for this one. Try Dealroom → on loans to football club 1. FC Köln.
The signal: The breadth of mandates — spanning a $12 billion pharma-services takeover, defence consolidation, chip technology, and an IPO — points to sustained deal activity across German and European markets, keeping the leading law firms busy on both sides of the table.
Read more: Börsen-Zeitung
Image credit: Generated with Gemini
